Provider review
Wisp review
Semaglutide as drops under the tongue rather than an injection, and a candid sourcing note.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
$225/mo sublingual semaglutide drops, after a $99 consult
Visit WispThe bottle is sold by volume with no concentration, so the one calculation the format makes easy is the one you cannot do.
Price as published
Wisp
$225/mo sublingual semaglutide drops, after a $99 consult
- Vs median
- $50/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The interesting thing here is the route. Almost everything on this page is a weekly subcutaneous injection, and for a reader deliberately holding a small dose that vehicle is the awkward part — a quarter dose means drawing a partial unit and trusting the markings on a syringe. Drops under the tongue sidestep that entirely, and Wisp is one of a handful of sellers offering them as a stocked product with a published price rather than something quoted on request. Two caveats travel with it, and Wisp states both itself rather than leaving them to be found. The first is that the product is described by volume and not by concentration, so there is no milligram anywhere: you cannot work out what a dose costs, how many doses a bottle holds, or whether taking less makes the bottle last longer, which is precisely the calculation the format would otherwise make easy. The second is in the footer, where the company discloses that the medications it offers are globally sourced and not FDA-approved and that the purchaser assumes that risk. That is a more candid disclosure than most of this category offers and it is also a material fact about provenance. The branded injectables are a different product entirely — prescriptions routed to a local pharmacy, with the pharmacy setting the price.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want a needle-free route as a stocked product with a price, not quoted on request
- You would rather a seller state its sourcing plainly than leave you to work it out
- You have coverage and want branded prescriptions routed to your own pharmacy
Look elsewhere if
- You want to cost a specific dose. The bottle is sold by volume with no concentration
- You want one charge. A consult is billed before the medication figure applies
- You want a product tested in people rather than on tissue. The company says which this is
What it actually costs
Price as published
$225/mo sublingual semaglutide drops, after a $99 consult
- Vs median
- $50/mo above the $175 median across the 299 of 548 programs here that publish a plain monthly rate
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
235 of the 548 programs here price a small dose this way. A stocked sublingual product with a published price rather than injections only, which matters for a small dose because a drop count is easier to control than a partial unit in a syringe. The bottle is sold by volume with no concentration published, so you cannot work out what a dose costs or whether taking less makes the bottle last longer, the one calculation the format would otherwise make easy. A consult is charged separately before the medication price applies. The site's own footer says its medications are globally sourced and not FDA-approved. The branded injectables are sent to a local pharmacy and priced there, not here.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Confirm any separate fee
- Dietitian
- Not confirmed
- Labs
- Not required
- Pricing
- Check plan terms
What it does well
- A stocked sublingual product with a published price, rather than injections only.
- Discloses the sourcing and the regulatory status of its medications in its own footer.
- Branded prescriptions can be routed to a local pharmacy for anyone with coverage.
Pharmacy, labs and oversight
Wisp does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. Confirm whether clinician visits cost extra.
Transparency check
2 of 4 published openly
What Wisp publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
The interesting thing here is the route. Almost every seller here sells a weekly subcutaneous injection, and for a reader deliberately holding a small dose that vehicle is the awkward part — a quarter dose means drawing a partial unit and trusting the markings on a syringe. Drops under the tongue sidestep that entirely, and Wisp is one of a handful of sellers offering them as a stocked product with a published price rather than something quoted on request. Two caveats travel with it, and Wisp states both itself rather than leaving them to be found. The first is that the product is described by volume and not by concentration, so there is no milligram anywhere: a reader cannot work out what a dose costs, how many doses a bottle holds, or whether taking less makes the bottle last longer, which is precisely the calculation the format would otherwise make easy. The second is in the footer, where the company discloses that the medications it offers are globally sourced and not FDA-approved and that the purchaser is assuming that risk. That is a more candid disclosure than most of this category offers and it is also a material fact about provenance. The branded injectables are a different product entirely — prescriptions routed to a local pharmacy, with the pharmacy setting the price.
The honest cons
The bottle is sold by volume with no concentration, so no dose can be costed.
- A consult is charged separately before the medication figure applies.
- The company states the sublingual base was tested on tissue rather than in people.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Wisp is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way Wisp does. Both are partners: we may earn a commission if you start care through these links.
Partner
RxSpan MD
$249/mo month to month ($199 on 6-mo)
Standard plan, self-directed low dose
Partner
HealthRX
$190/mo sema · $239/mo tirz (monthly plan)
Standard plan, self-directed low dose
Where this sits
#238 of 548
Ordered with the companies that pay us first, and Wisp is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Sublingual troches and drops
- Is compounded GLP-1 safe?
- Microdose & reconstitution calculator
- The true annual cost of a plan
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Willow
From $299/mo covering all four formats, none priced separately
- Vs median
- $124/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Willow review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.